Table 2 Demographical and clinical characteristics

Time since AD diagnosis (years)

2.7 ± 2.6

NA

–

Age (years)

71.9 ± 6.6

68.6 ± 8.4

0.193*

Sex (male/female)

7/10

12/9

0.267^‡

Body mass index (kg/m²)

24.9 ± 2.9

26.0 ± 4.4

0.412*

Eye (right/left)

10/7

10/12

0.408^‡

MMSE

17.6 ± 5.5

29.3 ± 0.9

< 0.001^†

BCVA (logMAR)

0.14 ± 0.11

0.06 ± 0.08

0.027*

IOP (mmHg)

14 ± 3

15 ± 4

0.359*

Phakic (yes/no)

15/2

12/10

0.024^‡

Vertical cup/disc ratio

0.52 ± 0.15

0.51 ± 0.21

0.878*

RNFL_AVG (μm)

84.8 ± 7.5

92.1 ± 7.3

0.005^§

RNFL_SUP (μm)

104.2 ± 8.9

109.8 ± 12.4

0.019^§

RNFL_INF (μm)

104.3 ± 11.1

115.6 ± 11.4

0.009^§

RNFL_TEM (μm)

63.3 ± 8.1

70.4 ± 6.7

0.069^§

RNFL_NAS (μm)

66.3 ± 11.7

72.7 ± 8.6

0.012^§